Pharmacologic treatment of type 2 diabetes.
Bloomgarden
Zachary T
ZT
The Diabetes Center, Mount Sinai School of Medicine, New York, New York, USA.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D000077270:Exenatide; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism; D054439:Ghrelin; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D009765:Obesity / Q000188:drug therapy; D010446:Peptide Fragments / Q000378:metabolism; D036361:Peptide Hormones / Q000378:metabolism; D010455:Peptides / Q000627:therapeutic use; D020025:Peroxisome Proliferators / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D013844:Thiazoles / Q000627:therapeutic use; D014688:Venoms
D054439:Ghrelin; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D010446:Peptide Fragments; D036361:Peptide Hormones; D010455:Peptides; D020025:Peroxisome Proliferators; D011498:Protein Precursors; D011956:Receptors, Cell Surface; D013844:Thiazoles; D014688:Venoms; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D000077270:Exenatide; D005947:Glucose